News

Pharmabiz18h
Osivax publishes phase 2a results of OVX836-004 study; supports co-administration of OVX836 with seasonal flu vaccine
Osivax publishes phase 2a results of OVX836-004 study; supports co-administration of OVX836 with seasonal flu vaccine: Lyon, France Saturday, July 12, 2025, 18:00 Hrs [IST] Osivax ...
Pharmabiz21h
Onco-Innovations appoints Dr. Islam Mohamed as advisory board chair to accelerate development of innovative oncology solutions
Onco-Innovations appoints Dr. Islam Mohamed as advisory board chair to accelerate development of innovative oncology solutions: Vancouver, BC Saturday, July 12, 2025, 14:30 Hrs [I ...
Pharmabiz20h
Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations
Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations: Cambridge, UK Saturday, July 12, 2025, 16: ...
Pharmabiz22h
UKHSA data shows 85% of parents are confident childhood vaccines are safe, effective and trustworthy
UKHSA data shows 85% of parents are confident childhood vaccines are safe, effective and trustworthy: United Kingdom Saturday, July 12, 2025, 14:00 Hrs [IST] New data published by ...
Pharmabiz21h
US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis
US FDA grants orphan drug designation to Klotho Neurosciences’ KLTO-202 to treat amyotrophic lateral sclerosis: New York Saturday, July 12, 2025, 15:00 Hrs [IST] Klotho Neurosci ...
Pharmabiz23h
Intelligent Bio Solutions to present pharmacokinetic study data at ADLM 2025 Clinical Lab Expo
Intelligent Bio Solutions to present pharmacokinetic study data at ADLM 2025 Clinical Lab Expo: New York Saturday, July 12, 2025, 13:00 Hrs [IST] Intelligent Bio Solutions Inc, a ...